Allakos Inc
Edit

Allakos Inc

https://www.allakos.com/
Last activity: 19.09.2022
Categories: SkinResearchLifeHealthTechDrugBioTech
Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.
Followers
3.17K
Mentions
9
Location: United States, California, Redwood City
Employees: 51-200
Total raised: $292M

Investors 6

Funding Rounds 4

DateSeriesAmountInvestors
19.09.2022-$150M-
13.12.2017Series B$100M-
30.09.2014-$10M-
17.12.2012Series A$32M-

Mentions in press and media 9

DateTitleDescriptionSource
19.09.2022Allakos Announces Pricing of $150 Million Underwritten Offer...-tcgcrossov...
13.12.2017Allergy, inflammation player Allakos reels in $100M series B...Five years after bagging a modest $30 million in series A financing, Allakos has picked up a hefty $...fiercebiot...
13.12.2017Allakos Secures $100 Million In Series B Financing-lifesciven...
13.12.2017Allergy, inflammation player Allakos reels in $100M series BFive years after bagging a modest $30 million in series A financing, Allakos has picked up a hefty $...fiercebiot...
30.09.2014Allakos Raises $10M in FundingAllakos, a San Francisco Bay Area-based biotechnology company, raised an additional $10m in funding....finsmes.co...
30.09.2014Allakos Raises Additional $10M SAN CARLOS, CA, Allakos Inc. announced today that it has secured an additional $10 million investm...vcnewsdail...
17.12.2012Allakos Grabs $32M Series A SAN MATEO, CA, Allakos announced today that it has completed a $32 million Series A preferred stoc...vcnewsdail...
17.12.2012Allakos Completes $32M Series A FinancingAllakos Inc., a San Francisco Bay Area-based biotechnology company, has completed a $32m Series A fi...finsmes.co...
-Allakos Announces Pricing of $150 Million Underwritten Offer...-tcgcrossov...

Reviews 0

Sign up to leave a review

Sign up Log In